Endometrial Cancer Clinical Trials
A PHASE 2 OPEN LABEL STUDY OF SACITUZUMABGOVITECAN (IMMU-132) IN SUBJECTS WITHMETASTATIC SOLID TUMORS:
Schedule a Consultation Today!
Your health is important, and we welcome the opportunity to help you heal.
To schedule an appointment, please call Beverly Hills Cancer Center in Beverly Hills, California at (877) 320-5131 or use our interactive Online Appointment Request Form.